138 related articles for article (PubMed ID: 34729651)
1. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.
Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
J Bone Miner Metab; 2022 Jan; 40(1):157-166. PubMed ID: 34729651
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
3. Cataract Surgery and Chronic Kidney Disease: A Hospital-based Prospective Cohort Study.
Wakasugi M; Yokoseki A; Wada M; Yoshino T; Momotsu T; Sato K; Kawashima H; Nakamura K; Fukuchi T; Onodera O; Narita I
Intern Med; 2024 May; 63(9):1207-1216. PubMed ID: 37779071
[TBL] [Abstract][Full Text] [Related]
4. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
[TBL] [Abstract][Full Text] [Related]
5. The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK.
de Bruin IJA; Wyers CE; Souverein PC; van Staa TP; Geusens PPMM; van den Bergh JPW; de Vries F; Driessen JHM
Osteoporos Int; 2020 Aug; 31(8):1487-1497. PubMed ID: 32266436
[TBL] [Abstract][Full Text] [Related]
6. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
[TBL] [Abstract][Full Text] [Related]
7. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
[TBL] [Abstract][Full Text] [Related]
8. Vegetable and Fruit Intake Frequency and Mortality in Patients With and Without Chronic Kidney Disease: A Hospital-Based Cohort Study.
Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
J Ren Nutr; 2023 Jul; 33(4):566-574. PubMed ID: 36791982
[TBL] [Abstract][Full Text] [Related]
9. Association of polypharmacy with incidence of CKD: a retrospective cohort study.
Kimura H; Tanaka K; Saito H; Iwasaki T; Watanabe S; Kazama S; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2023 Mar; 27(3):272-278. PubMed ID: 36574106
[TBL] [Abstract][Full Text] [Related]
10. Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults.
Mielke N; Barghouth MH; Fietz AK; Villain C; Bothe T; Ebert N; Schaeffner E
BMC Geriatr; 2024 Apr; 24(1):335. PubMed ID: 38609867
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and fracture risk in older individuals with CKD.
Yenchek RH; Ix JH; Shlipak MG; Bauer DC; Rianon NJ; Kritchevsky SB; Harris TB; Newman AB; Cauley JA; Fried LF;
Clin J Am Soc Nephrol; 2012 Jul; 7(7):1130-6. PubMed ID: 22516286
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999-2018.
Wang X; Yang C; Jiang J; Hu Y; Hao Y; Dong JY
Front Public Health; 2023; 11():1116583. PubMed ID: 37033012
[TBL] [Abstract][Full Text] [Related]
13. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.
Runesson B; Trevisan M; Iseri K; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
Nephrol Dial Transplant; 2020 Nov; 35(11):1908-1915. PubMed ID: 31361316
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic kidney disease on outcomes following proximal humerus fragility fracture surgery in diabetic patients: A nationwide population-based cohort study.
Chen CT; Lin SJ; Kuo LT; Chen TH; Hsu WH; Chen CL; Yu PA; Peng KT; Tsai YH
PLoS One; 2021; 16(10):e0258393. PubMed ID: 34624055
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease.
Min HK; Sung SA; Chung W; Kim YH; Chae DW; Ahn C; Oh KH; Park SK; Lee SW
Kidney Blood Press Res; 2021; 46(4):460-468. PubMed ID: 34091449
[TBL] [Abstract][Full Text] [Related]
16. Association of Respiratory Tuberculosis with Incident Bone Fracture: Bridging the Tuberculosis Airway Infection and the Osteoporotic Bone.
Yeh JJ; Wang YC; Lin CC; Lin CL; Hsu WH
PLoS One; 2016; 11(12):e0168673. PubMed ID: 28005963
[TBL] [Abstract][Full Text] [Related]
17. Hip fracture in patients with non-dialysis chronic kidney disease stage 5.
Tang CH; Chou CY
Sci Rep; 2021 Oct; 11(1):20591. PubMed ID: 34663840
[TBL] [Abstract][Full Text] [Related]
18. Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis.
Vilaca T; Salam S; Schini M; Harnan S; Sutton A; Poku E; Allen IE; Cummings SR; Eastell R
Am J Kidney Dis; 2020 Oct; 76(4):521-532. PubMed ID: 32654892
[TBL] [Abstract][Full Text] [Related]
19. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
Sutaria A; Liu L; Ahmed Z
Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
[TBL] [Abstract][Full Text] [Related]
20. Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.
Hall RK; Sloane R; Pieper C; Van Houtven C; LaFleur J; Adler R; Colón-Emeric C
J Am Geriatr Soc; 2018 Mar; 66(3):532-538. PubMed ID: 29319880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
